• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与外源性雌激素治疗相关的子宫内膜癌的变化趋势及预后特征

Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy.

作者信息

Robboy S J, Bradley R

出版信息

Obstet Gynecol. 1979 Sep;54(3):269-77.

PMID:471366
Abstract

A study was undertaken to investigate changing trends in the microscopic patterns of endometrial carcinoma and to compare the biologic characteristics of those cases associated with and without estrogen usage. After each case was reviewed independently and in a random order by at least 2 pathologists, a diagnosis of cancer was agreed on in 274 patients who had been treated by 5 gynecologists at the Masachusetts General Hospital between 1940 and 1971. Six microscopic patterns were identified (adenocarcinoma, adenoacanthoma, atypical adenoacanthoma, adenosquamous carcinoma, clear-cell adenocarcinoma, and undifferentiated carcinoma). The frequency of each pattern relative to the other 5 changed only slightly during the 30-year interval. The tumors that developed in estrogen users were more highly differentiated than those that developed in nonusers (P less than 0.005) and were found at an earlier average age (P less than 0.02). That the adenoacanthoma was associated with estrogen usage more frequently (51%) than any other tumor type (P less than 0.02) may reflect, in part, a similar and lower mean age of estrogen users (56 years) and patients with adenoacanthoma (55 years) compared with that of nonusers with the other forms of tumors (60--67 years). Although the overall 5- and 10-year survival rates of the estrogen users were higher than those of the nonusers, the differences between the 2 groups disappeared when the grade of the neoplasm was considered.

摘要

开展了一项研究,以调查子宫内膜癌微观模式的变化趋势,并比较使用和未使用雌激素的病例的生物学特征。在至少2名病理学家独立且随机地对每个病例进行复查后,对1940年至1971年间在马萨诸塞州总医院由5名妇科医生治疗的274例患者确诊为癌症。识别出六种微观模式(腺癌、腺棘皮癌、非典型腺棘皮癌、腺鳞癌、透明细胞腺癌和未分化癌)。在30年的时间间隔内,每种模式相对于其他5种模式的频率变化很小。使用雌激素的患者所患肿瘤的分化程度高于未使用雌激素的患者(P<0.005),且发病的平均年龄更早(P<0.02)。腺棘皮癌与雌激素使用的关联比其他任何肿瘤类型都更频繁(51%)(P<0.02),这可能部分反映了与其他形式肿瘤的未使用者(60 - 67岁)相比,雌激素使用者(56岁)和腺棘皮癌患者(55岁)的平均年龄相似且较低。尽管使用雌激素的患者的总体5年和10年生存率高于未使用者,但在考虑肿瘤分级时,两组之间的差异消失了。

相似文献

1
Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy.与外源性雌激素治疗相关的子宫内膜癌的变化趋势及预后特征
Obstet Gynecol. 1979 Sep;54(3):269-77.
2
Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma.
Obstet Gynecol. 1986 Aug;68(2):245-50.
3
Estrogen regimen of women with endometrial carcinoma. A retrospective case-control study at Radiumhemmet.子宫内膜癌女性的雌激素治疗方案。镭疗医院的一项回顾性病例对照研究。
Acta Obstet Gynecol Scand. 1981;60(2):191-7.
4
Estrogens and endometrial carcinoma.雌激素与子宫内膜癌
Obstet Gynecol. 1977 Apr;49(4):385-9.
5
Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma.子宫内膜癌中的鳞状分化:腺棘皮瘤和腺鳞癌的批判性评估。
Semin Diagn Pathol. 1988 May;5(2):154-71.
6
Carcinoma of the endometrium.子宫内膜癌
Obstet Gynecol Annu. 1984;13:211-60.
7
Association of exogenous estrogen and endometrial carcinoma.外源性雌激素与子宫内膜癌的关联。
N Engl J Med. 1975 Dec 4;293(23):1164-7. doi: 10.1056/NEJM197512042932302.
8
Review of epidemiologic studies of endometrial cancer and exogenous estrogen.子宫内膜癌与外源性雌激素的流行病学研究综述。
Obstet Gynecol. 1979 Oct;54(4):521-6.
9
[Histology and prognosis of endometrial carcinoma].
Gan No Rinsho. 1987 Dec;33(15):1897-900.
10
[Prognostic factors of endometrial carcinoma: a study of 98 cases].[子宫内膜癌的预后因素:98例病例研究]
Zhonghua Fu Chan Ke Za Zhi. 1993 Mar;28(3):150-2, 188.

引用本文的文献

1
Prospective cohort of pre-diagnosis hormone exposure and post-diagnosis sex hormone levels with survival outcomes: Alberta Endometrial Cancer Cohort Study.诊断前激素暴露与诊断后性激素水平及生存结局的前瞻性队列研究:艾伯塔省子宫内膜癌队列研究
Endocr Oncol. 2025 Mar 18;5(1):e240066. doi: 10.1530/EO-24-0066. eCollection 2025 Jan.
2
Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.子宫内膜癌诊断后病因学因素与死亡率之间的关联:NRG肿瘤学/妇科肿瘤学组210试验
Gynecol Oncol. 2015 Oct;139(1):70-6. doi: 10.1016/j.ygyno.2015.08.022. Epub 2015 Sep 1.
3
Menopausal hormone therapy and mortality among endometrial cancer patients in the NIH-AARP Diet and Health Study.
美国国立卫生研究院-美国退休人员协会饮食与健康研究中子宫内膜癌患者的绝经激素治疗与死亡率
Cancer Causes Control. 2015 Aug;26(8):1055-63. doi: 10.1007/s10552-015-0598-0. Epub 2015 May 12.
4
Menopausal hormone therapy and risk of endometrial cancer.绝经激素治疗与子宫内膜癌风险。
J Steroid Biochem Mol Biol. 2014 Jul;142:83-9. doi: 10.1016/j.jsbmb.2013.05.001. Epub 2013 May 13.
5
The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients.绝经激素治疗对子宫内膜癌患者肿瘤特征和生存的影响。
Eur J Cancer. 2009 Nov;45(17):3064-73. doi: 10.1016/j.ejca.2009.05.012. Epub 2009 Jun 1.
6
Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium.体重指数作为子宫内膜样腺癌的预后因素
J Natl Med Assoc. 2006 Nov;98(11):1814-22.
7
Establishment and characterization of a human uterine endometrial undifferentiated carcinoma cell line, TMG-L.
Hum Cell. 2003 Mar;16(1):31-8. doi: 10.1111/j.1749-0774.2003.tb00126.x.
8
Lewis rats of the inbred strain LEW/Han: life expectancy, spectrum and incidence of spontaneous neoplasms.近交系LEW/Han的Lewis大鼠:预期寿命、自发性肿瘤的谱和发生率。
Exp Toxicol Pathol. 1995 Jan;47(1):11-8. doi: 10.1016/S0940-2993(11)80275-7.
9
Estrogens and endometrial cancer: some answers and some further questions.雌激素与子宫内膜癌:一些答案及更多问题
Can Med Assoc J. 1981 May 1;124(9):1129-31.
10
Should postmenopausal women be given estrogen?绝经后女性应该服用雌激素吗?
West J Med. 1985 May;142(5):672-7.